The past year has seen a gold rush in AI applications for the biopharma sector, for drug and protein discovery, or even treatment repurposing.
AI has completely shifted the paradigm in the biotech industry. The past year has seen a gold rush in AI applications for the biopharma sector, for drug and protein discovery, or even treatment repurposing. Indeed, AI has had a few success stories in 2023 and will keep improving the field.